Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Gema Requena, Victoria Banks, Alexandrosz Czira, Robert Wood, Theo Tritton, Rosie Wild, Chris Compton, Maria Duarte & Afisi S Ismaila. (2022) Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Dual Therapy in a Primary Care Setting in England. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1781-1795.
Read now
Read now
Henrik Watz, Kathleen Rickard, Tara Rheault, Thomas Bengtsson & Dave Singh. (2020) Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD – A Detailed Analysis. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2199-2206.
Read now
Read now
Ike Iheanacho, Shiyuan Zhang, Denise King, Maria Rizzo & Afisi S Ismaila. (2020) Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 439-460.
Read now
Read now
Mark D. Danese, Michelle Gleeson, Robert I. Griffiths, David Catterick & Lucie Kutikova. (2017) Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom. Journal of Medical Economics 20:9, pages 931-937.
Read now
Read now
Margarethe E Wacker, Katharina Kitzing, Rudolf A Jörres, Reiner Leidl, Holger Schulz, Stefan Karrasch, Annika Karch, Armin Koch, Claus F Vogelmeier & Rolf Holle. (2017) The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3437-3448.
Read now
Read now
Kieran J Rothnie, Hana Müllerová, Sara L Thomas, Joht S Chandan, Liam Smeeth, John R Hurst, Kourtney Davis & Jennifer K Quint. (2016) Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records. Clinical Epidemiology 8, pages 771-782.
Read now
Read now
Roland Buhl, Carl-Peter Criée, Peter Kardos, Claus Vogelmeier, Nadine Lossi, Claudia Mailänder & Heinrich Worth. (2016) A year in the life of German patients with COPD: the DACCORD observational study. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1639-1646.
Read now
Read now
Articles from other publishers (4)
Alexandrosz Czira, Victoria Banks, Gema Requena, Robert Wood, Theo Tritton, Rosie Wild, Chris Compton, Maria Duarte & Afisi S Ismaila. (2022)
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β
2
-agonist dual therapy in a primary care setting in England
. BMJ Open Respiratory Research 9:1, pages e001243.
Crossref
Crossref
E. A. Orlova, A. R. Umerova, I. P. Dorfman, M. A. Orlov & M. A. Abdullaev. (2021) ЕSTIMATION OF SOCIO-ECONOMIC BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE FOR A 5-YEAR PERIOD: A REGIONAL ASPECT. Pharmacy & Pharmacology 9:2, pages 130-138.
Crossref
Crossref
Marina Labor, Žarko Vrbica, Ivan Gudelj, Slavica Labor & Davor Plavec. (2016) Diagnostic accuracy of a pocket screening spirometer in diagnosing chronic obstructive pulmonary disease in general practice: a cross sectional validation study using tertiary care as a reference. BMC Family Practice 17:1.
Crossref
Crossref
Yogesh Suresh Punekar, Sarah H Landis, Keele Wurst & Hoa Le. (2015) Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care. Respiratory Research 16:1.
Crossref
Crossref